Friday, June 26, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,769
Drugs linked 4,797

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 825 of 1,261

  1. US 8679557

    Synergistic herbal ophthalmic formulation for lowering the intra ocular pressure in case of glaucoma

    SENTISS PHARMA PRIVATE LIMITED · Granted Mar 25, 2014 · Expires Mar 20, 2034

    granted

  2. US 8680021

    Zinc finger proteins for DNA binding and gene regulation in plants

    Sangamo Biosciences, Inc. · Granted Mar 25, 2014 · Expires Mar 20, 2034

    granted

  3. US 8680046

    Inhibitors of viral integrase and methods of use

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Mar 25, 2014 · Expires Mar 20, 2034

    granted

  4. US 8680083

    Controlled release corticosteroid compositions and methods for the treatment of otic disorders

    The Regents of the University of California · Granted Mar 25, 2014 · Expires Mar 20, 2034

    granted

  5. US 8680094

    1, 4-benzoxazine compounds and derivatives thereof as therapeutic drugs for the treatment of neurodegenerative conditions

    The Board of Regents of the University of Texas System · Granted Mar 25, 2014 · Expires Mar 20, 2034

    granted

  6. US 8680132

    Spiro-oxindole MDM2 antagonists

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Mar 25, 2014 · Expires Mar 20, 2034

    granted

  7. US 8680319

    Method for producing antifolate agents having glutamic acid part in their structure

    Kocak Farma Ilac ve Kimya Sanayi A.S. · Granted Mar 25, 2014 · Expires Mar 20, 2034

    granted

  8. US 8680082

    Controlled release corticosteroid compositions and methods for the treatment of otic disorders

    The Regents of the University of California · Granted Mar 25, 2014 · Expires Mar 20, 2034

    granted

  9. US 8680066

    Methods for determining and inhibiting rheumatoid arthritis associated with the BRAF oncogene in a subject

    The United States of America as represented by the Development of Veterans Affairs · Granted Mar 25, 2014 · Expires Mar 20, 2034

    granted

  10. US 8680065

    Oligonucleotides of human endogenous retrovirus 9 (ERV-9) long terminal repeat (LTR) and methods of use

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Mar 25, 2014 · Expires Mar 20, 2034

    granted

  11. US 8679476

    Interferon-β production modulating Listeria strains and methods for using same

    The Regents of the University of California · Granted Mar 25, 2014 · Expires Mar 20, 2034

    granted

  12. US 8679489

    Inhibiting cell migration

    XBIOTECH INC. · Granted Mar 25, 2014 · Expires Mar 20, 2034

    granted

  13. US 8680084

    Oral contraceptives to prevent pregnancy and diminish premenstrual symptomatology

    TEVA WOMEN'S HEALTH, INC. · Granted Mar 25, 2014 · Expires Mar 20, 2034

    granted

  14. US 8680056

    Antiproliferative factor and methods of use

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Mar 25, 2014 · Expires Mar 20, 2034

    granted

  15. US 8679545

    Topical corticosteroids for the treatment of inflammatory diseases of the gastrointestinal tract

    The Regents of the University of California · Granted Mar 25, 2014 · Expires Mar 20, 2034

    granted

  16. US 8680022

    Methods and compositions

    BICYCLE THERAPEUTICS LIMITED · Granted Mar 25, 2014 · Expires Mar 20, 2034

    granted

  17. US 8673964

    Use of drug combinations for treating insulin resistance

    DiaMedica Inc. · Granted Mar 18, 2014 · Expires Mar 13, 2034

    granted

  18. US 8673942

    Fused ring compounds and use thereof

    Takeda Pharmaceutical Company Limited · Granted Mar 18, 2014 · Expires Mar 13, 2034

    granted

  19. US 8673888

    Depsipeptide for therapy of kidney cancer

    THE UNITED STATES OF AMERICA, represented by the Secretary, Department of Health and Human Services · Granted Mar 18, 2014 · Expires Mar 13, 2034

    granted

  20. US 8673897

    Benzodiazepinone compounds and methods of treatment using same

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Mar 18, 2014 · Expires Mar 13, 2034

    granted

  21. US 8673954

    Benzimidazole derivatives

    Enanta Pharmaceuticals, Inc. · Granted Mar 18, 2014 · Expires Mar 13, 2034

    granted

  22. US 8674115

    CRTH2 modulators

    IRONWOOD PHARMACEUTICALS, INC. · Granted Mar 18, 2014 · Expires Mar 13, 2034

    granted

  23. US 8674108

    Solid forms of N-[2,4-bis(1,1-dimethylethy)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide

    Vertex Pharmaceuticals Incorporated · Granted Mar 18, 2014 · Expires Mar 13, 2034

    granted

  24. US 8674118

    Compounds and methods for the treatment or prevention of flavivirus infections

    Vertex Pharmaceuticals Incorporated · Granted Mar 18, 2014 · Expires Mar 13, 2034

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.